The novel genetic information gained from genome-wide high throughput techniques has
greatly improved our understanding of peripheral T-cell lymphoma (PTCL). PTCL consists of …

Abstract Epstein–Barr virus (EBV)-associated diffuse large B-cell lymphoma not otherwise
specified (DLBCL NOS) constitute a distinct clinicopathological entity in the current World …

B-cell lymphoproliferative disorders exhibit a diverse spectrum of diagnostic entities with
heterogeneous behaviour. Multiple efforts have focused on the determination of the genomic …

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic malignancy with
variable prognosis. It represents 15% of diagnosed pediatric ALL cases and has a threefold …

Subclonal genetic heterogeneity and their diverse gene expression impose serious
problems in understanding the behavior of cancers and contemplating therapeutic …

T-cell lymphoblastic lymphoma (T-LBL) represents the second most common subtype of non-
Hodgkin's lymphoma (NHL) in children and adolescents. Current chemotherapy protocols …

T-cell lymphoblastic lymphoma (T-LBL) and T-cell acute lymphoblastic leukemia (T-ALL)
have common and distinguishing clinical and molecular features. Molecular prognostic …

Background: Mature T-cell lymphomas and leukemias (MTCL) are heterogeneous diseases
with dismal prognosis. Differentiating between the numerous entities requires specialized …

Objective To explore the correlation of mutation landscape with clinical outcomes in patients
with peripheral T-cell lymphoma (PTCL). Methods We retrospectively analyzed the …

Fusions transcripts have been proven to be strong drivers for neoplasia-associated
mutations, although their incidence in T-cell lymphoblastic lymphoma needs to be …